As of April 2024 KOBAYASHI Pharmaceutical has a market cap of $2.64 Billion. This makes KOBAYASHI Pharmaceutical the world's 3648th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $2.64 B | -26.08% |
2023 | $3.57 B | -30.39% |
2022 | $5.13 B | -15.96% |
2021 | $6.10 B | -36.1% |
2020 | $9.55 B | 43.62% |
2019 | $6.65 B | 24.31% |
2018 | $5.35 B | 4.64% |
2017 | $5.11 B | 43.88% |
2016 | $3.55 B | 5.41% |
2015 | $3.37 B | 39.8% |
2014 | $2.41 B | 5.35% |
2013 | $2.29 B | 17.28% |
2012 | $1.95 B | -8.54% |
2011 | $2.13 B | 12.72% |
2010 | $1.89 B | 15.56% |
2009 | $1.63 B | -8.99% |
2008 | $1.80 B | 13.15% |
2007 | $1.59 B | 3.32% |
2006 | $1.54 B |
On Apr 25th, 2024 the market cap of KOBAYASHI Pharmaceutical was reported to be: